Liontrust GF Spec Sits C3 Instl Acc £
Pricing frequency
Daily
Dealing cut off time
10:44
Type
OEIC
Yield
–
NAV
£25.6899
Income frequency
-
Ongoing charge
1.92%
Latest actual NAV date
13-11-2026
ISIN
IE00B8CL0730
UCITS
Yes
Growth of 10k
Asset allocation
Top 10 holdings
| Holdings 31/10/2026 | % of assets |
|---|---|
| Shell PLC | 3.81 |
| RELX PLC | 3.66 |
| Compass Group PLC | 3.35 |
| AstraZeneca PLC | 3.33 |
| Gamma Communications PLC | 3.29 |
| BP PLC | 3.22 |
| GSK PLC | 3.20 |
| Moonpig Group PLC Ordinary Shares | 3.05 |
| Unilever PLC | 2.85 |
| Sage Group (The) PLC | 2.83 |
Investment objective
The investment objective of the Fund is to provide long-term capital growth. The Investment Adviser believes the best way to achieve this growth is by investing in equities of companies in a special situation. These companies are in a special situation because they have certain special characteristics that are difficult to replicate, distinct from their competitors and that enables them to sustain a higher level of profitability for longer than expected which often surprises the market and typically leads to strong share price appreciation. Examples of the characteristics that identify a company in a special situation are: (i) protected intellectual property rights, (ii) strong distribution networks or (iii) significant recurring income, which is defined as at least 70% of the company’s annual turnover.
This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.